SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019285
Filing Date
2023-11-21
Accepted
2023-11-21 17:15:44
Documents
15
Period of Report
2023-11-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20231117x8k.htm   iXBRL 8-K 38844
2 EX-10.1 cydy-20231117xex10d1.htm EX-10.1 63986
3 EX-99.1 cydy-20231117xex99d1.htm EX-99.1 15984
4 GRAPHIC cydy-20231117xex99d1001.jpg GRAPHIC 5373
  Complete submission text file 0001558370-23-019285.txt   257569

Data Files

Seq Description Document Type Size
5 EX-101.SCH cydy-20231117.xsd EX-101.SCH 3132
6 EX-101.LAB cydy-20231117_lab.xml EX-101.LAB 14110
7 EX-101.PRE cydy-20231117_pre.xml EX-101.PRE 9209
9 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20231117x8k_htm.xml XML 4345
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 231429137
SIC: 2834 Pharmaceutical Preparations